文献速递甲状腺与颈部外科

1000例连续单孔腋窝入路机器人甲状腺切除术的围手术期与肿瘤学结局

Perioperative and oncologic outcomes of 1,000 consecutive single-port transaxillary robotic thyroidectomy (SP-TART).
PubMed 文献 · Surg Endosc · 2026-07-29

该研究回顾性分析了2021至2025年间单中心1000例连续接受da Vinci单孔腋窝入路机器人甲状腺切除术(SP-TART)的患者,评估围手术期结局、早期肿瘤学结果及并发症危险因素。结果显示围手术期结局可接受,短期随访早期复发率低,手术范围与甲状旁腺功能减退相关,而喉返神经损伤与肿瘤负荷及局部侵袭性更相关。

要点

  • SP-TART在以低危甲状腺癌为主的大队列中围手术期结局可接受。
  • 暂时性和永久性甲状旁腺功能减退发生率分别为7.4%和0.4%。
  • 暂时性和永久性喉返神经损伤发生率分别为4.1%和0.2%。

核心结论

  • SP-TART在主要为低危甲状腺癌患者的大连续队列中显示出可接受的围手术期结局和短期随访的低早期复发率。
  • 手术范围与甲状旁腺功能减退密切相关,而喉返神经损伤与肿瘤负荷和局部侵袭性关系更强。

研究设计与样本

  • 回顾性队列研究,纳入2021至2025年间单机构连续1000例接受da Vinci SP-TART的患者。
  • 收集围手术期结局、术后并发症及临床病理数据,采用逻辑回归分析喉返神经损伤和甲状旁腺功能减退的相关因素。

主要发现

  • 平均年龄40.9±11.6岁,女性占87.2%。
  • 手术方式:小于全甲状腺切除83.0%,全甲状腺切除8.9%,补充甲状腺切除0.4%,改良根治性颈淋巴结清扫7.7%。
  • 平均手术时间79.1±42.0分钟。
  • 最终病理恶性占85.1%,良性占11.6%,非侵袭性包裹性滤泡性肿瘤伴乳头状核特征占3.3%;恶性病例中乳头状甲状腺癌占98.2%,平均肿瘤大小1.1±0.9 cm。
  • 平均随访22.7±13.3个月,复发率0.8%,无疾病特异性死亡。

关键数值与推荐

  • 暂时性甲状旁腺功能减退(≤12个月)发生率7.4%,永久性(>12个月)0.4%。
  • 暂时性喉返神经损伤(经术后喉镜检查确认)发生率4.1%,永久性0.2%。
  • 在小于全甲状腺切除队列中,较大肿瘤尺寸和肉眼甲状腺外侵犯与喉返神经损伤独立相关。
  • 在全甲状腺切除/补充甲状腺切除/改良根治性颈淋巴结清扫队列中,未发现甲状旁腺功能减退的独立危险因素。

临床怎么用

  • SP-TART可用于经过选择的甲状腺癌患者,尤其是低危病例。
  • 应关注手术范围对甲状旁腺功能的影响,以及肿瘤负荷和局部侵袭性对喉返神经损伤的风险。

局限性

  • 回顾性单中心研究设计。
  • 随访时间较短(平均22.7个月),早期复发率需更长期验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Evidence on single-port transaxillary robotic thyroidectomy (SP-TART) remains limited. We evaluated perioperative outcomes, early oncologic results, and complication-specific risk factors in a large consecutive SP-TART cohort. METHODS: We retrospectively reviewed 1,000 consecutive patients who underwent da Vinci SP-TART at a single institution between 2021 and 2025. Perioperative outcomes, postoperative complications, and clinicopathologic data were collected from medical records and final pathology reports. Hypoparathyroidism was classified as transient (≤ 12 months) or permanent (> 12 months), and recurrent laryngeal nerve (RLN) injury was confirmed by postoperative laryngoscopy. Logistic regression analyses were performed to identify factors associated with RLN injury and hypoparathyroidism. RESULTS: Mean age was 40.9 ± 11.6 years, and 87.2% of patients were female. Less-than-total thyroidectomy was performed in 83.0%, total thyroidectomy in 8.9%, completion thyroidectomy in 0.4%, and modified radical neck dissection in 7.7%. Mean operative time was 79.1 ± 42.0 min. Final pathology was malignant in 85.1%, benign in 11.6%, and noninvasive follicular thyroid neoplasm with papillary-like nuclear features in 3.3%. Among malignant cases, papillary thyroid carcinoma accounted for 98.2%, and mean tumor size was 1.1 ± 0.9 cm. Major postoperative complications included transient and permanent hypoparathyroidism in 7.4 and 0.4%, respectively, and transient and permanent RLN injury in 4.1 and 0.2%, respectively. During a mean follow-up of 22.7 ± 13.3 months, recurrence occurred in 0.8%, with no disease-specific mortality. In the less-than-total cohort, larger tumor size and gross extrathyroidal extension were independently associated with RLN injury. In the total thyroidectomy/completion thyroidectomy/modified radical neck dissection cohort, no independent risk factor for hypoparathyroidism was identified. CONCLUSIONS: SP-TART demonstrated acceptable perioperative outcomes and low early recurrence during short-term follow-up in a large consecutive cohort predominantly composed of low-risk thyroid cancer patients. Surgical extent was closely associated with hypoparathyroidism, whereas RLN injury was more strongly related to tumor burden and local invasiveness.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Park J, An S, Bae JS, et al. Perioperative and oncologic outcomes of 1,000 consecutive single-port transaxillary robotic thyroidectomy (SP-TART). Surg Endosc. 2026. PMID: 42527738. doi:10.1007/s00464-026-13193-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。